AMA Journal of Ethics^®

More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline.

Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients.

This article applies principlism to what a “shoppable service” model would demand of clinicians in practice.

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions.

Mark Rukavina joins Ethics Talk to discuss how consumer advocacy groups can help advance health justice and equity.

Practice ownership shifts to various employment models have amplified the problem of physician-employees of some US health care companies not knowing about services billed in their names.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.

Abigail E. Lowe joins Ethics Talk to discuss her article, coauthored with Dr Shawn G. Gibbs: “How Should Health Care Organizations Protect Personnel in Environmental Services and Related Fields?”

All health workers should be included in planning personal protective equipment access and infectious disease containment operations.